The aim of this study was to investigate the biochemical effects of niacin and chromium(III)-chloride on serum lipid peroxidation, uric and sialic acids, and the extent of lipid peroxidation and glutathione levels in skin and lung tissues of hyperlipidemic rats.
In this study, female Swiss albino rats, 12 mo old, were used. They were randomly divided into four groups. Group I animals were fed with a standard pellet diet and water ad libitium. Group II rats were fed with a standard pellet diet and were treated with a dose of 250 μg/kg body weight CrCI3·6H2O and 100 mg/kg body weight niacin, for 45 d, by the gavage technique. Group III rats were fed a lipogenic diet in which 2% cholesterol, 0.5% cholic acid, and 20% sunflower oil were added to the pellet chow. In addition, the animals in this group drank water containing 3% ethanol. This regime was maintained for 60 d. The rats in group IV were maintained in the same food and drink regime as the animals in group III. After 2 wk, the animals showed symptoms of hyperlipemia and they were treated with 250 μg/kg body weight CrCI3·6H2O and 100 mg/kg body weight niacin, by gavage, for 45 d. On d 60, the blood and the skin and lungs samples were taken from animals.
In the hyperlipemic groups, a reduction of the lung glutathione level and an increase in serum, lung, and skin lipid peroxidation levels and in serum sialic and uric acid were observed. In rats treated with a combination of niacin and Cr(III), the skin and serum lipid peroxidation and the sialic and uric acid levels decreased while showing an increase of lung glutathione activity. These results suggest that niacin and Cr(III), when administered in combination, have a protective effect against skin and lung tissues damage as a result of hyperlipidemia.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
A. Onat, Risk factors and cardiovascular disease in Turkey, Atherosclerosis 156, 1–10 (2001).
D. Kromhout, Diet and cardiovascular diseases, J. Nutr. Health Aging 5, 144–149 (2001).
S. K. Wattanapitayakul and J. A. Bauer, Oxidative pathways in cardiovascular disease roles, mechanisms and therapeutic implications, Pharmacol. Ther. Pharmacol. 89, 187–206 (2001).
H. Esterbauer, G. Wag, and H. Puhl, Lipid peroxidation and its role in atherosclerosis, Br. Med. Bull. 49, 566–576 (1993).
J. P. De La Cruz, L. Quintero, M. A. Villalobos, and F. S. De La Cuesta, Lipid peroxidation and glutathione system in hyperlipemic rabbits: influence of olive oil administration, Biochim. Biophys. Acta 1485, 36–44 (2000).
S. Kajanachumpol, et al., Plasma lipid peroxide and antioxidant levels in diabetic patients, J. Med. Assoc. Thal. 80, 372–377 (1999).
B. Halliwel, Drug antioxidant effects, Drugs 42, 569–605 (1991).
J. Loeper, J. Goy, L. Rosensztajn, O. Bedu, and P. Moisson, Lipid peroxidation and protective enzymes during myocardial infarction, Clin. Chim. Acta 196, 119–126 (1991).
D. M. Colquhoun, Nutraceuticals: vitamins and other nutrients in coronary heart disease, Curr. Opin. Lipidol. 12, 639–646 (2001).
S. B. Lall, S. Bhoopendra, K. Gulati, and S. D. Seth, Role of nutrition in toxic injury, Indian J. Exp. Biol. 37, 109–116 (1999).
L. Raij, J. Nagy, K. Coffee, and E. G. DeMaster, Hypercholesterolemia promotes endothelial dysfunction in vitamin E- and selenium-deficient rats, Hypertension 22, 56–61 (1993).
S. S. Melo, M. R. Arantes, M. S. Meirelles, A. A. Jordao, and H. Vannuchi, Lipid peroxidation in nicotinamide-deficient and nicotinamide-supplemented rats with streptozotocin-induced diabetes, Acta Diabetol. 37, 33–39 (2000).
R. A. Anderson, N. A. Bryden, and M. M. Polansky, Lack of toxicity of chromium chloride and chromium picolinate in rats, J. Am. Coll. Nutr. 16, 273–279 (1997).
M. Simonoff, Chromium deficiency and cardiovascular risk, Cardiovasc. Res. 18, 591–596 (1984).
T. Zima, O. Mestek, V. Tesar, et al., Chromium levels in patients with internal diseases, Biochem. Mol. Biol. Int. 46, 365–374 (1998).
H. L. Figge, J. Figge, P. M. Souney, A. H. Mutnick, and F. Sacks, Nicotinic acid: a review of its clinical use in the treatment of lipid disorders, Pharmacotherapy 8, 287–294 (1988).
J. R. Dipalma and W. S. Thayer, Use of niacin as a drug, Annu. Rev. Nutr. 11, 169–187 (1991).
A. C. Goldberg, Clinical trial experience with extended-release niacin (Niaspan): doseescalation study, Am. J. Cardiol. 82, 35–38 (1998).
D. M. Capuzzi, J. M. Morgan, A. O. Brusco, and C. M. Intenzo, Niacin dosing: relationship to benefits and adverse effects, Curr. Atherosclerosis Rep. 2, 64–71 (2000).
A. Blazovics, J. Feher, E. Feher, A. K. Petri, and G. Petri, Liver protecting and lipid lowering effects of Sempervivum tectorum extract in the rat, Phytother. Res. 7, 98–100 (1993).
J. Ledwozyw, J. Michalak, A. Stepien, and A. Kadziolka, The relationship plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis, Clin. Chim. Acta 155, 275–284 (1986).
K. Yagi, Assay for blood plasma or serum, Methods Enzymol. 105, 328–337 (1984).
E. Beutler, Glutathione, in Red Cell Metabolism: A Manual of Biochemical Methods, 2nd ed., Grune and Stratton, New York, pp. 112–114 (1975).
H. O. Lowry, J. N. Rosebrough, A. L. Farr, and J. R. Randall, Protein measurement with the folin phenol reagent, J. Biol. Chem. 193, 265–275 (1951).
K. Lorentz, T. Weiss, and E. Kraas, Sialic acid in human serum and cerebrospinal fluid, comparison of methods and references value, Clin. Chem. Clin. Biochem. 24, 189–198 (1986).
W. T. Caraway, Determination of uric acid in serum by a carbonate method, Am. J. Clin. Pathol. 25, 840–845 (1955).
J. L. Hintze, Copyright C, 865, East 400, North Kaysville, Utah, 84037, (801), 546–0445, (1986).
M. F. Maggi-Capeyron, J. Cases, E. Badia, et al., A diet high in cholesterol and deficient in vitamin E induces lipid peroxidation but does not enhance antioxidant enzyme expression in rat liver, J. Nutr. Biochem. 13, 296–301 (2002).
R. I. Press, J. Geller, and G. W. Evans, The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects, West. J. Med. 152, 41–45 (1990).
L. Gate, J. Paul, G. N. Ba, K. D. Tew, and H. Tapiero, Oxidative stress induced in pathologies: the role of antioxidants, Biomed. Pharmacother. 53, 169–180 (1999).
Y. Z. Fang, S. Yang, and G. Wu, Free radicals, antioxidants and nutrition, Nutr. 18, 872–879 (2002).
R. Kohen, Skin antioxidants: their role in aging and in oxidative stress—new approaches for their evaluation, Biomed. Pharmacother. 53, 181–192 (1999).
R. A. Kozar, C. J. Weibel, J. Cipolla, et al., Antioxidant enzymes are induced during recovery from acute lung injury, Crit. Care Med. 28, 2486–2491 (2000).
K. Kedziora Kornatowska, S. Szram, T. Kornatowski, et al., The effect of verapamil on the antioxidant defence system in diabetic kidney, Clin. Chim. Acta 322, 105–112 (2002).
M. Hoyos, J. M. Guerrero, R. Perez Cano, et al., Serum cholesterol and lipid peroxidation are decreased by melatonin in diet-induced hypercholesterolemic rats, J. Pineal Res. 28, 150–155 (2000).
F. J. Kelly, Glutathione in defence of the lung, Food Chem. Toxicol. 37, 963–966 (1999).
I. Seghrouchni, J. Drai, E. Bannier, et al., Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency, Clin. Chim. Acta 321, 89–96 (2002).
S. H. Ganji, V. S. Kamanna, and M. L. Kashyap, Niacin and cholesterol: role in cardiovascular disease. [review], J. Nutr. Biochem. 14, 298–305 (2003).
M. H. Davidson, Niacin: a powerful adjunct to other lipid-lowering drugs in reducing plaque progression and acute coronary events, Curr. Atherosclerosis Rep. 5, 418–422 (2003).
D. R. Illingworth, E. A. Stein, Y. B. Mitchel, et al., Comparative effects of lovastatin and niacin in primary hypercholesterolemia a prospective trial, Arch. Intern. Med. 154, 1586–1595 (1994).
P. Evans and B. Halliwell, Micronutrients: oxidant/antioxidant status, Br. J. Nutr. 85, 67–74 (2001).
Y. Fang, S. Yang, and G. Wu, Free radicals, antioxidants, and nutrition, Nutrition 18, 872–879 (2002).
S. Davies, J. Howard, and A. Hunnisett, Age-related decreases in chromium levels in 51,665 hair, sweat and serum samples from 40,872 patients-implications for the prevention of cardiovascular disease and type II diabetes mellitus, Metabolism 46, 469–473 (1997).
S. Ueno, N. Susa, Y. Furukawa, et al., Effects of chromium in lipid peroxidation in isolated hepatocytes, Jpn. J. Sci. 50, 45–52 (1998).
H. G. Preuss, S. T. Jarrell, R. Scheckenbach, S. Lieberman, and R. A. Anderson, Comparative effects of chromium, vanadium and gymnema sylvestre on sugar-induced blood pressure elevations in SHR, J. Am. Coll. Nutr. 17, 116–123 (1998).
R. A. Anderson, A. Roussel, N. Zouari, S. Mahjoub, J. Matheau, and A. Kerkeni, Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus, J. Am. Coll. Nutr. 20, 212–218 (2001).
M. Onderci, N. Sahin, K. Sahin, and N. Kiliç, Antioxidant properties of chromium and zinc: in vivo effects on digestibility, lipid peroxidation, antioxidant vitamins, and some minerals under a low ambient temperature, Biol. Trace Element Res. 92, 139–150 (2003).
H. H. Cheng, M. H. Lai, W. C. Hou, and C. L. Huang, Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects, J. Agric. Food Chem. 52, 1385–1389 (2004).
M. Tezuka, S. Ishii, and S. Okada, Chromium(III) decreases carbon tetrachloride originated trichloromethyl radical in mice, Biochemistry 44, 261–265 (1991).
Y. Ohara, T. E. Peterson, and D. G. Harison, Hypercholesterolemia increases endothelial superoxide anion production, J. Clin. Invest. 91, 2546–2551 (1993).
E. Tremoli, P. Maderna, M. Sirtori, and C. Sirtori, Platelet aggregation and malondialdehyde formation in type IIA hypercholesterolemic patients, Haemostasis 8, 47–53 (1979).
M. Saladini, L. Menaube, and E. Ferrari, Binding ability of sialic acid towards biological and toxic metal ions. NMR, potentiometric and spectroscopic study, J. Inorg. Biochem. 88, 61–68 (2002).
P. Sillanaukee, M. Pönniö, and K. Seppa, Sialic acid: new potential marker of alcohol abuse, Alcohol. Clin. Exp. Res. 23, 1039–1043 (1999).
P. J. Waters, E. Lewry, and C. A. Pennock, Measurement of sialic acid in serum and urine: clinical applications and limitations, Ann. Clin. Biochem. 29, 625–637 (1992).
S. Ekin, I. Meral, H. Gunduz, and N. Mert, Comparative study of total protein and total and lipid-associated serum sialic acid levels in patients with type 2 diabetes mellitus, J. Clin. Lab. Anal. 17, 124–126 (2003).
About this article
Cite this article
yanardag, R., Peksel, A., Yesilyaprak, B. et al. Effects of a combination of niacin and chromium(III)-chloride on the skin and lungs of hyperlipemic rats. Biol Trace Elem Res 103, 249–260 (2005). https://doi.org/10.1385/BTER:103:3:249
- lipid peroxidation
- sialic acid
- uric acid